Ottoboni L, Frohlich IY, Lee M, et al. Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus. Neurology. 2013;81(22):1891-9. doi:10.1212/01.wnl.0000436612.66328.8a
Francis JM, Kiezun A, Ramos AH, et al. Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet. 2013;45(12):1483-6. doi:10.1038/ng.2821
Johannessen CM, Johnson LA, Piccioni F, et al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition. Nature. 2013;504(7478):138-42. doi:10.1038/nature12688
Federation AJ, Bradner JE, Meissner A. The use of small molecules in somatic-cell reprogramming. Trends Cell Biol. 2014;24(3):179-87. doi:10.1016/j.tcb.2013.09.011
McCarroll SA, Hyman SE. Progress in the genetics of polygenic brain disorders: significant new challenges for neurobiology. Neuron. 2013;80(3):578-87. doi:10.1016/j.neuron.2013.10.046
Amir A, Zeisel A, Zuk O, et al. High-resolution microbial community reconstruction by integrating short reads from multiple 16S rRNA regions. Nucleic Acids Res. 2013;41(22):e205. doi:10.1093/nar/gkt1070
Kleinewietfeld M, Hafler DA. The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol. 2013;25(4):305-12. doi:10.1016/j.smim.2013.10.009
Williams WW, Pollak MR. Health disparities in kidney disease--emerging data from the human genome. N Engl J Med. 2013;369(23):2260-1. doi:10.1056/NEJMe1312797
Ljosa V, Caie PD, Horst RT, et al. Comparison of methods for image-based profiling of cellular morphological responses to small-molecule treatment. J Biomol Screen. 2013;18(10):1321-9. doi:10.1177/1087057113503553
Xia Z, Secor E, Chibnik LB, et al. Modeling disease severity in multiple sclerosis using electronic health records. PLoS One. 2013;8(11):e78927. doi:10.1371/journal.pone.0078927